Your browser doesn't support javascript.
loading
Microscopic Analysis and Quality Assessment of Induced Sputum From Children With Pneumonia in the PERCH Study.
Murdoch, David R; Morpeth, Susan C; Hammitt, Laura L; Driscoll, Amanda J; Watson, Nora L; Baggett, Henry C; Brooks, W Abdullah; Deloria Knoll, Maria; Feikin, Daniel R; Kotloff, Karen L; Levine, Orin S; Madhi, Shabir A; O'Brien, Katherine L; Scott, J Anthony G; Thea, Donald M; Ahmed, Dilruba; Awori, Juliet O; DeLuca, Andrea N; Ebruke, Bernard E; Higdon, Melissa M; Jorakate, Possawat; Karron, Ruth A; Kazungu, Sidi; Kwenda, Geoffrey; Hossain, Lokman; Makprasert, Sirirat; Moore, David P; Mudau, Azwifarwi; Mwaba, John; Panchalingam, Sandra; Park, Daniel E; Prosperi, Christine; Salaudeen, Rasheed; Toure, Aliou; Zeger, Scott L; Howie, Stephen R C.
Afiliación
  • Murdoch DR; Department of Pathology, University of Otago, and.
  • Morpeth SC; Microbiology Unit, Canterbury Health Laboratories, Christchurch, New Zealand.
  • Hammitt LL; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi.
  • Driscoll AJ; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, United Kingdom.
  • Watson NL; Microbiology Laboratory, Middlemore Hospital, Counties Manukau District Health Board, Auckland, New Zealand.
  • Baggett HC; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi.
  • Brooks WA; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore and.
  • Deloria Knoll M; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore and.
  • Feikin DR; Emmes Corporation, Rockville, Maryland.
  • Kotloff KL; Global Disease Detection Center, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi.
  • Levine OS; Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Madhi SA; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • O'Brien KL; International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka and Matlab.
  • Scott JAG; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore and.
  • Thea DM; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore and.
  • Ahmed D; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Awori JO; Division of Infectious Disease and Tropical Pediatrics, Department of Pediatrics, Center for Vaccine Development, Institute of Global Health, University of Maryland School of Medicine, Baltimore.
  • DeLuca AN; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore and.
  • Ebruke BE; Bill & Melinda Gates Foundation, Seattle, Washington.
  • Higdon MM; Medical Research Council, Respiratory and Meningeal Pathogens Research Unit and.
  • Jorakate P; Department of Science and Technology/National Research Foundation, Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Karron RA; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore and.
  • Kazungu S; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi.
  • Kwenda G; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, United Kingdom.
  • Hossain L; Center for Global Health and Development, Boston University School of Public Health, Massachusetts.
  • Makprasert S; International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka and Matlab.
  • Moore DP; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi.
  • Mudau A; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore and.
  • Mwaba J; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Panchalingam S; Medical Research Council Unit, Basse, The Gambia.
  • Park DE; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore and.
  • Prosperi C; Global Disease Detection Center, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi.
  • Salaudeen R; Department of International Health, Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Toure A; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi.
  • Zeger SL; Department of Biomedical Sciences, School of Health Sciences, University of Zambia, and.
  • Howie SRC; Zambia Center for Applied Health Research and Development, Lusaka.
Clin Infect Dis ; 64(suppl_3): S271-S279, 2017 Jun 15.
Article en En | MEDLINE | ID: mdl-28575360
ABSTRACT
BACKGROUND. It is standard practice for laboratories to assess the cellular quality of expectorated sputum specimens to check that they originated from the lower respiratory tract. The presence of low numbers of squamous epithelial cells (SECs) and high numbers of polymorphonuclear (PMN) cells are regarded as indicative of a lower respiratory tract specimen. However, these quality ratings have never been evaluated for induced sputum specimens from children with suspected pneumonia. METHODS. We evaluated induced sputum Gram stain smears and cultures from hospitalized children aged 1-59 months enrolled in a large study of community-acquired pneumonia. We hypothesized that a specimen representative of the lower respiratory tract will contain smaller quantities of oropharyngeal flora and be more likely to have a predominance of potential pathogens compared to a specimen containing mainly saliva. The prevalence of potential pathogens cultured from induced sputum specimens and quantity of oropharyngeal flora were compared for different quantities of SECs and PMNs. RESULTS. Of 3772 induced sputum specimens, 2608 (69%) had <10 SECs per low-power field (LPF) and 2350 (62%) had >25 PMNs per LPF, measures traditionally associated with specimens from the lower respiratory tract in adults. Using isolation of low quantities of oropharyngeal flora and higher prevalence of potential pathogens as markers of higher quality, <10 SECs per LPF (but not >25 PMNs per LPF) was the microscopic variable most associated with high quality of induced sputum. CONCLUSIONS. Quantity of SECs may be a useful quality measure of induced sputum from young children with pneumonia.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neumonía / Esputo / Neumonía Bacteriana Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2017 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neumonía / Esputo / Neumonía Bacteriana Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2017 Tipo del documento: Article